Navigation Links
InterTech Development Company UDI System Announced
Date:4/19/2010

Medical device manufacturers seeking to comply with the FDA Amendments Act of 2007 and to enhance patient safety with complete part traceability, can now use the InterTech Development (www.intertechdevelopment.com) Unique Device Identifier (UDI) System, which integrates bar coding, scan and software tracking of each part and batch, including all leak test, functional test and lifecycle test data related to each component

(Vocus) -- Medical device manufacturers seeking to comply with the FDA Amendments Act of 2007 and to enhance patient safety with complete part traceability, can now use the InterTech Development (www.intertechdevelopment.com) Unique Device Identifier (UDI) System, which integrates bar coding, scan and software tracking of each part and batch, including all leak test, functional test and lifecycle test data related to each component (http://www.intertechdevelopment.com/instrumentation_detail.cgi?id_num=143 ).

The InterTech Development UDI System not only provides full traceability in the event of product recalls, but also provides data for process optimization to streamline production, and storage of all test data at each productions stage for SPC (Statistical Process Control) data that underlies most quality assurance systems and full ISO 13485:2003 compliance.

For added traceability, a laser marking system can be integrated with the bar code label system.

Jacques Hoffmann, President of InterTech Development Company, comments, “InterTech’s turnkey test solutions have always emphasized software integration to monitor all stages of testing and archive all test data. Above and beyond the UDI system finalized by the FDA for minimum parts traceability requirements, the InterTech UDI system will enable device manufacturers to glean from constantly archiving test data the process improvements they need to make to improve yield, minimize defects, and ensuring that products jeopardizing patient safety are never released to market.”

For more information on the InterTech UDI system or other test technology for the medical device industry please contact Gerald Sim, gsim(at)intertechdevelopment(dot)com,: +847 679 3377, fax: +847 679 3391.

InterTech Development Company (www.intertechdevelopment.com) is a world leader in test-centric assembly and test specializing in automated leak and functional testing with 7 patented mass flow and hydraulic technologies, as well as, helium mass spectrometry (ISO-17025 International Standards for Quality Management). InterTech Development Company-engineered solutions are used by hundreds of manufacturers worldwide. InterTech Development Company’s worldwide support organization maintains offices in North America, Asia, and Europe.


For all editorial inquiries, please contact Amy Munice, ALM Communications, +773 – 862 – 6800, skype-ALMCommunications, alm(at)almcommunications(dot)com.

###

Read the full story at http://www.prweb.com/releases/2010/04/prweb3895804.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related biology technology :

1. Dates Announced for IntertechPira's 5th Annual Biopolymers Symposium
2. Clet Niyikiza, Merrimack's Executive Vice President of Development, to Present at BioVisionAlexandria 2010
3. NIST scientists address wrinkles in transparent film development
4. Michael J. Fox Foundation Offers High-Quality LRRK2 Antibodies for PD Therapeutic Development
5. Cellular Dynamics and Roche Conduct Stem Cells in Drug Discovery and Development Workshop at the Society of Toxicology Annual Meeting
6. AFFiRiS AG: Vaccination Against Hypertension is Development Project No. 4 and has Already Been Awarded an FFG Grant of up to EUR 1.2 Million
7. Predicted Second Wave of Biotech Growth and Development Begins
8. Advanced Instruments Signs License and Sensor Development Agreement With Cantimer, Inc.
9. Evonik Extends Long-term Research & Development Partnership with Genedata
10. Astrogenetix Continues MRSA Vaccine Development Onboard Endeavor
11. Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ComplianceOnline’s Medical ... place on 7th and 8th June 2018 in San Francisco, CA. The Summit brings ... well as several distinguished CEOs, board directors and government officials from around the world ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... and pregnancy rates in frozen and fresh in vitro fertilization (IVF) ... maternal age to IVF success. , After comparing the results from the fresh ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... Dr. Bob ... at his local San Diego Rotary Club. The event entitled “Stem ... CA and had 300+ attendees. Dr. Harman, DVM, MPVM was joined by two ...
(Date:10/9/2017)... , Oct. 9, 2017  BioTech Holdings announced ... by which its ProCell stem cell therapy prevents ... ischemia.  The Company, demonstrated that treatment with ProCell ... limbs saved as compared to standard bone marrow ... HGF resulted in reduction of therapeutic effect.  ...
Breaking Biology Technology:
(Date:10/4/2017)... Oct. 4, 2017  GCE Solutions, a global clinical research organization ... document anonymization solution on October 4, 2017. Shadow is designed to ... comply with policy 0070 of the European Medicines Agency (EMA) in ... ... ...
(Date:6/23/2017)... and ITHACA, N.Y. , ... and Cornell University, a leader in dairy research, today ... bioinformatics designed to help reduce the chances that the ... the onset of this dairy project, Cornell University has ... for Sequencing the Food Supply Chain, a food safety ...
(Date:5/6/2017)... May 5, 2017 RAM Group ... a new breakthrough in biometric authentication based on ... mechanical properties to perform biometric authentication. These new sensors ... material created by Ram Group and its partners. This ... transportation, supply chains and security. Ram Group is ...
Breaking Biology News(10 mins):